Albumin-HMchitosanGTMAC-based nanoparticles as potential controlled release delivery systems of curcumin

Dorota Bielska 1Katarzyna Krzysztofek Anna Karewicz Maria Nowakowska 

1. Jagiellonian University, Faculty of Chemistry, Ingardena 3, Kraków 30-060, Poland


Curcumin is a natural polyphenol derived from a traditional herbal remedy. It shows the promising anti-inflammatory, anti-cancer and anti-oxidant activities. It is, however, only sparingly soluble in water and therefore its bioavailability is very low.As a solution to that problem we propose a new type of hybrid nanocarrier for effective curcumin.  The carrier is  based on bovine serum albumin (BSA) and N-dodecyl-N-glycidyltrimethylammonium-chitosan (HMchitosanGTMAC). Albumin is  known for its extraordinary ligand binding capacity and non-covalent reversible binding characteristics. Chitosan is a cationic, biocompatible polymer. Stable aqueous dispersion of bovine serum albumin (BSA) nanoparticles NPs containing curcumin was obtained by a coacervation process followed by electrostaticly driven  adsorption of cationic N-dodecyl-N-glycidyltrimethylammonium-chitosan (HMchitosanGTMAC) on the  NP surfaces. Variuos concentrations of HMchitGTMAC were used  for coating of  BSA NPs to stabilize the colloidal system and to control the release of curcumin. The physicochemical properties of the resulting objects were then studied. The size and surface potential of the nanoparticles were evaluated using dynamic light scattering (DLS) measurements. The morphology of the unloaded and curcumin-loaded nanocarriers was evaluated by Atomic Force Microscopy (AFM) and by Scanning Electron Microscopy (SEM). The binding constant (Ka) of curcumin to bovine serum albumin (BSA) and curcumin release profiles were determined. The high Ka value and plausible release profiles suggest that our novel delivery system, based on albumin, may act as an effective carrier for curcumin. 










Acknowledgements: Project operated within the Foundation for Polish Science Team Programme co-financed by the EU European Regional Development Fund, PolyMed, TEAM/2008-2/6.

Legal notice
  • Legal notice:

    Copyright (c) Pielaszek Research, all rights reserved.
    The above materials, including auxiliary resources, are subject to Publisher's copyright and the Author(s) intellectual rights. Without limiting Author(s) rights under respective Copyright Transfer Agreement, no part of the above documents may be reproduced without the express written permission of Pielaszek Research, the Publisher. Express permission from the Author(s) is required to use the above materials for academic purposes, such as lectures or scientific presentations.
    In every case, proper references including Author(s) name(s) and URL of this webpage: must be provided.


Related papers
  1. Nano/micro drug carriers
  2. Studies on the inhibition mechanism of the human coronavirus NL63 replication by polycations
  3. Polisacharydowo-białkowe membrany do rekonstrukcji rogówki
  4. Protoporphyrine IX and its PEI derivatives as possible photosensitizer in antibacterial photodynamic therapy
  5. Novel nanostructural photosensitizers for photodynamic therapy
  6. Selective adsorbents of adenosine-5'-triphosphate
  7. Novel polymeric inhibitors of human coronavirus NL63
  8. Superparamagnetyczne nanocząstki tlenku żelaza opłaszczane pochodnymi chitozanu – nowe kontrasty do MRI
  9. Polymeric Nanocapsules for Controlled Delivery of Lipophilic Drugs
  10. Dextran-based materials reducing anticoagulant activity of heparin in animal models in vitro and in vivo
  11. Preliminary studies on a new way of nucleic acids extraction using hydrogel microsphere
  12. Properties of DODAB/oleyl alcohol and DODAB/cholesterol monolayers and bilayers
  13. Synthesis and physicochemical properties of cationic chitosan derivative for heparin complexation
  14. Cationic chitosan derivative for heparin reversal - in vitro and in vivo studies in rats

Presentation: Poster at Nano-Biotechnologia PL, by Dorota Bielska
See On-line Journal of Nano-Biotechnologia PL

Submitted: 2012-06-29 10:52
Revised:   2012-06-29 10:54
© 1998-2021 pielaszek research, all rights reserved Powered by the Conference Engine